Skip to main content

About this Research Topic

Abstract Submission Deadline 15 May 2023
Manuscript Submission Deadline 15 September 2023

Neglected tropical diseases (NTDs) are a group of several tropical diseases that affect low-income countries. These diseases affect more than one billion people worldwide, predominantly in tropical and subtropical areas, causing severe social and economic impacts. Due to the low economic return, most big pharmaceutical companies do not invest much effort in developing new drugs for these conditions. For this reason, this group of diseases is named neglected. Within this context, some studies have shown that traditional drugs for NTDs can be improved when associated with different types of nanocarriers. The idea is to overcome some pharmacokinetic drawbacks, thus improving the therapy's effectiveness.

NTDs do not currently have effective pharmaceutical treatments. This Research Topic aims to discuss the use of nanotechnology and conventional drugs for treating different types of NTDs.

We ask authors to submit original research and review articles for this collection about the use of nanotechnology for the treatment of NTDs that may include topics such as:

- Nanoemulsions and NTDs

- Liposomes and NTDs

- Oral administration of nanoformulation for NTD therapy

- Polymeric nanoparticles for NTDs

- Organic and inorganic nanoparticles for NTD therapy

Keywords: nanotechnology, neglected disease, nanomedicine, tropical disease, pharmacokinetics, drug repositioning


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Neglected tropical diseases (NTDs) are a group of several tropical diseases that affect low-income countries. These diseases affect more than one billion people worldwide, predominantly in tropical and subtropical areas, causing severe social and economic impacts. Due to the low economic return, most big pharmaceutical companies do not invest much effort in developing new drugs for these conditions. For this reason, this group of diseases is named neglected. Within this context, some studies have shown that traditional drugs for NTDs can be improved when associated with different types of nanocarriers. The idea is to overcome some pharmacokinetic drawbacks, thus improving the therapy's effectiveness.

NTDs do not currently have effective pharmaceutical treatments. This Research Topic aims to discuss the use of nanotechnology and conventional drugs for treating different types of NTDs.

We ask authors to submit original research and review articles for this collection about the use of nanotechnology for the treatment of NTDs that may include topics such as:

- Nanoemulsions and NTDs

- Liposomes and NTDs

- Oral administration of nanoformulation for NTD therapy

- Polymeric nanoparticles for NTDs

- Organic and inorganic nanoparticles for NTD therapy

Keywords: nanotechnology, neglected disease, nanomedicine, tropical disease, pharmacokinetics, drug repositioning


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Topic Editors

Loading..

Topic Coordinators

Loading..

Articles

Sort by:

Loading..

Authors

Loading..

views

total views views downloads topic views

}
 
Top countries
Top referring sites
Loading..

Share on

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.